Open access
Open access
Powered by Google Translator Translator

Archives

Observational Study Suggests Possible Benefit from Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

21 May, 2020 | 09:23h | UTC

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 – Clinical Infectious Diseases

Related: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19

 


Olfactory Dysfunction in COVID-19: Diagnosis and Management

21 May, 2020 | 09:24h | UTC

Olfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA

Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford

 


Editorial: Unconventional Approaches to Mechanical Ventilation Through the COVID-19 Crisis

21 May, 2020 | 09:22h | UTC

Unconventional approaches to mechanical ventilation—step-by-step through the COVID-19 crisis – Critical Care

 


A Critical Look at A Preprint Inferring the Covid-19 Infection Fatality Rate

21 May, 2020 | 09:21h | UTC

A Critical Look at A Preprint Inferring the Covid-19 Infection Fatality Rate – by Hilda Bastian

Original Preprint: The infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv

 


Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease

21 May, 2020 | 09:18h | UTC

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy – European Heart Journal

Commentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology

 


Cardiovascular Considerations in Treating Patients with COVID-19

21 May, 2020 | 09:16h | UTC

Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19) – Journal of Cardiovascular Pharmacology

Related: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD

See also: COVID-19: Updates for Cardiologists

 


COVID-19 in Children: Clinical Approach and Management

21 May, 2020 | 09:19h | UTC

COVID-19 in Children: Clinical Approach and Management – The Indian Journal of Pediatrics

Related Systematic Reviews: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries) AND SARS-CoV-2 (COVID-19): What do we know about children? A systematic review – Clinical Infectious Diseases

 


Rate of Diagnostic Errors and Related Harms for Major Vascular Events, Infections, and Cancers

21 May, 2020 | 09:14h | UTC

Rate of diagnostic errors and serious misdiagnosis-related harms for major vascular events, infections, and cancers: toward a national incidence estimate using the “Big Three” – Diagnosis

Commentary: Misdiagnoses Common, With Permanent Disability, Death for Many – Medscape (free registration required)

 


Review: Artificial Intelligence and the Future of Global Health

21 May, 2020 | 09:11h | UTC

Artificial intelligence and the future of global health – The Lancet (free registration required)

 


Systematic Review: Safety and Adverse Effects of 80 Antidepressants, Antipsychotics, Anti‐attention‐deficit/hyperactivity Medications and Mood Stabilizers in Children and Adolescents

21 May, 2020 | 09:10h | UTC

Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects – World Psychiatry

 


Neurologic Complications of COVID-19

21 May, 2020 | 09:15h | UTC

Neurologic complications of COVID-19 – American Journal of Emergency Medicine

Related: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries) AND Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology

 


ASCO Guideline: Management of Cancer Cachexia

21 May, 2020 | 09:13h | UTC

Management of Cancer Cachexia: ASCO Guideline – Journal of Clinical Oncology

 


Thrombolysis with Alteplase 3–4.5 hours After Acute Ischemic Stroke: Trial Reanalysis Adjusted for Baseline Imbalances

21 May, 2020 | 09:09h | UTC

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances – BMJ Evidence-Based Medicine

 


Thu May 21 – 10 Stories of The Day!

21 May, 2020 | 09:29h | UTC

 

1 – SARS-CoV-2 infection protects against rechallenge in rhesus macaques – Science

Related Study: DNA vaccine protection against SARS-CoV-2 in rhesus macaques – Science

Commentaries: Infection With SARS-CoV-2 Protects Against Re-infection – At Least in Rhesus Macaques – Technology Networks AND Prototype Vaccine Protects Monkeys From Coronavirus – The New York Times

 

2 – Audio Interview: Capitalizing on Immune Responses to Covid-19 – New England Journal of Medicine

 

3 – Olfactory Dysfunction in COVID-19: Diagnosis and Management – JAMA

Related: Loss of smell and taste as symptoms of COVID-19: what does the evidence say? – CEBM Oxford

 

4 – Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 – Clinical Infectious Diseases

Related: Study Commentary: Before/after Study of Short-Course Steroid in COVID-19

 

5 – Unconventional approaches to mechanical ventilation—step-by-step through the COVID-19 crisis – Critical Care

 

6 – A Critical Look at A Preprint Inferring the Covid-19 Infection Fatality Rate – by Hilda Bastian

Original Preprint: The infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv

 

7 – COVID-19 in Children: Clinical Approach and Management – The Indian Journal of Pediatrics

Related Systematic Reviews: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries) AND SARS-CoV-2 (COVID-19): What do we know about children? A systematic review – Clinical Infectious Diseases

 

8 – Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy – European Heart Journal

Commentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology

 

9 – Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19) – Journal of Cardiovascular Pharmacology

Related: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD

See also: COVID-19: Updates for Cardiologists

 

10 –COVID-19 Updates / 21 May 2020 Edition

21 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious

20 May, 2020 | 10:00h | UTC

Covid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg

See also: People who recover from coronavirus and test positive again are NOT contagious: Korean CDC finds ‘re-positive’ patients did not infect any of their 790 contacts – Daily Mail

 


Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs

20 May, 2020 | 09:58h | UTC

Keep your nose out of it: why saliva tests could offer a better alternative to nasal COVID-19 swabs – The Conversation

Original Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics

Related Study: Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease-2019 (COVID-19): a cross-sectional study – Clinical Microbiology and Infection

 


Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19

20 May, 2020 | 10:01h | UTC

Lack of efficacy of hydroxychloroquine in covid-19 – The BMJ

Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ

Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv

 


Reducing the Risk of Diagnostic Error in the COVID-19 Era

20 May, 2020 | 09:57h | UTC

Reducing the Risk of Diagnostic Error in the COVID-19 Era – Journal of Hospital Medicine

 


Video: Personal Protective Equipment and Covid-19

20 May, 2020 | 09:55h | UTC

Personal Protective Equipment and Covid-19 – New England Journal of Medicine

 


Why do Some COVID-19 Patients Infect Many Others, Whereas Most Don’t Spread the Virus at All?

20 May, 2020 | 09:52h | UTC

Why do some COVID-19 patients infect many others, whereas most don’t spread the virus at all? – Science

 


Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City

20 May, 2020 | 09:56h | UTC

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study – The Lancet

Commentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI

 


Study Shows Lower Incidence of Hospitalization for Acute Myocardial Infarction After the Covid-19 Pandemic

20 May, 2020 | 09:54h | UTC

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction – New England Journal of Medicine

Related Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine

 


Serology for SARS-CoV-2: Apprehensions, Opportunities, and the Path Forward

20 May, 2020 | 09:53h | UTC

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward – Science Immunology

 


Lack of Cross-neutralization by SARS Patient Sera Towards SARS-CoV-2

20 May, 2020 | 09:49h | UTC

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 – Emerging Microbes & Infections

 


[Preprint] The Infection Fatality Rate of COVID-19 Inferred from Seroprevalence Data

20 May, 2020 | 09:51h | UTC

The infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv

 

Related Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.